Bottom line
What is MDARX's expense ratio?
MDARX's expense ratio is 1.06%, or about $106 a year on every $10,000 invested. That is more expensive than 64% of allocation / balanced funds we track (median 0.91%). It has no front-end sales load. Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated Aug 24, 2026
MDARX fee table
| Net expense ratio | 1.06% |
|---|---|
| Gross expense ratio | 1.06% |
| Management fee | 0.2% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 0.27% |
| Acquired fund fees | 0.09% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Aug 24, 2026
What MDARX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| MDARX | $108 | $337 | $585 | $1,294 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.06% expense ratio costs roughly $58,400 in lost growth, versus about $50,800 for the median allocation / balanced fund (0.91%).